Literature DB >> 30825062

Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.

Nozomi Matsumura1, Sumihito Nobusawa2, Junko Ito3, Akiyoshi Kakita3, Hiroyoshi Suzuki4, Yukihiko Fujii5, Masafumi Fukuda6, Masaki Iwasaki7, Nobukazu Nakasato8, Teiji Tominaga9, Atsushi Natsume10, Yoshiki Mikami11, Naoki Shinojima12, Tatsuya Yamazaki2, Yoichi Nakazato13, Junko Hirato14, Hideaki Yokoo2.   

Abstract

PURPOSE: Dysembryoplastic neuroepithelial tumors (DNTs) are slow-growing glioneuronal tumors, and their genetic backgrounds are getting unveiled. Recently, fibroblast growth factor receptor 1 internal tandem duplication (FGFR1-ITD) of the tyrosine kinase domain (TKD) has been demonstrated by whole-genome sequencing. METHODS AND
RESULTS: Here, we analyzed 22 DNTs using multiplex ligation-dependent probe amplification (MLPA) with formalin-fixed paraffin-embedded specimens and found a copy number gain in TKD of FGFR1 (13 cases, 59%), which suggested the presence of FGFR1-ITD. Another 5 DNTs harbored FGFR1 hot spot mutations including a double mutant case, and FGFR1 alterations were detected in 18 DNTs (82%). The BRAF V600E mutation, another important mutation in DNTs, was not observed.
CONCLUSIONS: With recent findings of less frequent or absent FGFR1-ITD in pilocytic astrocytomas or rosette-forming glioneuronal tumors, the analysis of FGFR1 aberrations, especially FGFR1-ITD, was suggested to be helpful to discriminate DNTs from their histological mimics.

Entities:  

Keywords:  DNT; FFPE; FGFR1 alteration; FGFR1-ITD; MLPA

Mesh:

Substances:

Year:  2019        PMID: 30825062     DOI: 10.1007/s11060-019-03138-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  3 in total

Review 1.  Molecular alterations of low-grade gliomas in young patients: Strategies and platforms for routine evaluation.

Authors:  Iman Dandapath; Rituparna Chakraborty; Kavneet Kaur; Swati Mahajan; Jyotsna Singh; Mehar C Sharma; Chitra Sarkar; Vaishali Suri
Journal:  Neurooncol Pract       Date:  2021-08-23

Review 2.  Oncogenic BRAF Alterations and Their Role in Brain Tumors.

Authors:  Felix Behling; Jens Schittenhelm
Journal:  Cancers (Basel)       Date:  2019-06-08       Impact factor: 6.639

Review 3.  Pediatric low-grade glioma in the era of molecular diagnostics.

Authors:  Scott Ryall; Uri Tabori; Cynthia Hawkins
Journal:  Acta Neuropathol Commun       Date:  2020-03-12       Impact factor: 7.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.